Trial Profile

Assessment of Cognitive Ability and the Intestinal Microbiome in Individuals With Liver Disease Before and After Investigational Microbiota Restoration Therapeutic

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 06 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs RBX 7455 (Primary)
Indications Hepatic encephalopathy
Focus Pharmacodynamics
Sponsors Rebiotix

Most Recent Events

29 Sep 2023 Status changed from recruiting to discontinued. Reason the study was stopped: Unable to recruit participants.
21 Apr 2023 Planned primary completion date changed from 1 Mar 2023 to 30 Jul 2023.
21 Sep 2021 Planned End Date changed from 1 Oct 2022 to 1 Oct 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com